Immunity, atherosclerosis and cardiovascular disease
Top Cited Papers
Open Access
- 1 May 2013
- journal article
- review article
- Published by Springer Science and Business Media LLC in BMC Medicine
- Vol. 11 (1), 1-13
- https://doi.org/10.1186/1741-7015-11-117
Abstract
Atherosclerosis, the major cause of cardiovascular disease (CVD), is a chronic inflammatory condition with immune competent cells in lesions producing mainly pro-inflammatory cytokines. Dead cells and oxidized forms of low density lipoproteins (oxLDL) are abundant. The major direct cause of CVD appears to be rupture of atherosclerotic plaques. oxLDL has proinflammatory and immune-stimulatory properties, causes cell death at higher concentrations and contains inflammatory phospholipids with phosphorylcholine (PC) as an interesting epitope. Antibodies against PC (anti-PC) may be atheroprotective, one mechanism being anti-inflammatory. Bacteria and virus have been discussed, but it has been difficult to find direct evidence, and antibiotic trials have not been successful. Heat shock proteins could be one major target for atherogenic immune reactions. More direct causes of plaque rupture include pro-inflammatory cytokines, chemokines, and lipid mediators. To prove that inflammation is a cause of atherosclerosis and CVD, clinical studies with anti-inflammatory and/or immune-modulatory treatment are needed. The potential causes of immune reactions and inflammation in atherosclerosis and how inflammation can be targeted therapeutically to provide novel treatments for CVD are reviewed.Keywords
This publication has 127 references indexed in Scilit:
- Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosisNature Medicine, 2013
- Human mortality improvement in evolutionary contextProceedings of the National Academy of Sciences of the United States of America, 2012
- Periodontal Disease and Atherosclerotic Vascular Disease: Does the Evidence Support an Independent Association?Circulation, 2012
- Lymphocytes and the Adventitial Immune Response in AtherosclerosisCirculation Research, 2012
- Systematic Review and Meta-Analysis of Methotrexate Use and Risk of Cardiovascular DiseaseThe American Journal of Cardiology, 2011
- Human oral, gut, and plaque microbiota in patients with atherosclerosisProceedings of the National Academy of Sciences of the United States of America, 2010
- Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasomeProceedings of the National Academy of Sciences of the United States of America, 2009
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive ProteinThe New England Journal of Medicine, 2008
- Pleiotropic effects of statin therapy: molecular mechanisms and clinical resultsTrends in Molecular Medicine, 2008
- Expression of 5-lipoxygenase and leukotriene A 4 hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instabilityProceedings of the National Academy of Sciences of the United States of America, 2006